Latest Breaking News On - Molecularly targeted - Page 1 : comparemela.com

Telix Pharmaceuticals Limited announces that Tiffany Olson has been appointed to the Board, as a U.S.-based independent, Non-Executive Director. Ms. Olson brings a depth of experience in commercialisation and corporate strategy in oncology, including in the radiopharmaceutical sector. Her most recent executive role was with Cardinal Health, the largest provider of radiopharmaceuticals in the United States,

United statesUniversity of minnesotaTiffany olsonCastle biosciencesKevin mccannEli lillyRisk committeeTelix pharmaceuticalsCardinal health nuclear precision solutionsThomas universityAustralian securities exchangeCardinal healthRoche diagnostics corporationTelix boardPharmaceuticals limitedCardinal health nuclear